{"id":830283,"date":"2025-03-26T17:08:05","date_gmt":"2025-03-26T21:08:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/"},"modified":"2025-03-26T17:08:05","modified_gmt":"2025-03-26T21:08:05","slug":"abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/","title":{"rendered":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies"},"content":{"rendered":"
\n

\n Abivax publishes financial reports with the French and U.S. securities regulatory agencies<\/strong>\n <\/p>\n

\n PARIS, France \u2013 March 26, 2025 \u2013 10:05 PM CET \u2013 <\/strong>Abivax SA (Euronext Paris & Nasdaq: ABVX) (\u201cAbivax\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company focused on developing therapeutics that harness the body\u2019s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announces the filing of its Universal Registration Document (Document d\u2019Enregistrement Universel) with the French Financial Market Authorities, Autorit\u00e9 des March\u00e9s Financiers (AMF), and the filing of its Annual Report (20-F) with the U.S. Securities and Exchange Commission (SEC) on March 24, 2025.<\/p>\n

The Universal Registration Document includes the 2024 annual financial report, the management report including the report on corporate governance, as well as the reports of the statutory auditors.<\/p>\n

The documents will be available for download on the website of Abivax (www.abivax.com\/investors<\/a>), the AMF (www.amf-france.org<\/a>), and the SEC (www.sec.gov\/edgar<\/a>).<\/p>\n

\n
\n
About Abivax <\/strong>\n <\/p>\n

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body\u2019s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Based in France and the United States, Abivax\u2019s lead drug candidate, obefazimod (ABX464), is in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis.<\/p>\n

\n
\n Contact:<\/strong>\n <\/p>\n

Patrick Malloy
SVP, Investor Relations
Abivax SA
patrick.malloy@abivax.com<\/a>
+1 847 987 4878<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France \u2013 March 26, 2025 \u2013 10:05 PM CET \u2013 Abivax SA (Euronext Paris & Nasdaq: ABVX) (\u201cAbivax\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company focused on developing therapeutics that harness the body\u2019s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announces the filing of its Universal Registration Document (Document d\u2019Enregistrement Universel) with the French Financial Market Authorities, Autorit\u00e9 des March\u00e9s Financiers (AMF), and the filing of its Annual Report (20-F) with the U.S. Securities and Exchange Commission (SEC) on March 24, 2025. The Universal Registration Document includes the 2024 annual financial report, the management report including the report on corporate … <\/p>\n

Continue reading “Abivax publishes financial reports with the French and U.S. securities regulatory agencies”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-830283","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAbivax publishes financial reports with the French and U.S. securities regulatory agencies - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abivax publishes financial reports with the French and U.S. securities regulatory agencies - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France \u2013 March 26, 2025 \u2013 10:05 PM CET \u2013 Abivax SA (Euronext Paris & Nasdaq: ABVX) (\u201cAbivax\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company focused on developing therapeutics that harness the body\u2019s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announces the filing of its Universal Registration Document (Document d\u2019Enregistrement Universel) with the French Financial Market Authorities, Autorit\u00e9 des March\u00e9s Financiers (AMF), and the filing of its Annual Report (20-F) with the U.S. Securities and Exchange Commission (SEC) on March 24, 2025. The Universal Registration Document includes the 2024 annual financial report, the management report including the report on corporate … Continue reading "Abivax publishes financial reports with the French and U.S. securities regulatory agencies"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-26T21:08:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Abivax publishes financial reports with the French and U.S. securities regulatory agencies\",\"datePublished\":\"2025-03-26T21:08:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/\"},\"wordCount\":238,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/\",\"name\":\"Abivax publishes financial reports with the French and U.S. securities regulatory agencies - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==\",\"datePublished\":\"2025-03-26T21:08:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abivax publishes financial reports with the French and U.S. securities regulatory agencies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/","og_locale":"en_US","og_type":"article","og_title":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies - Market Newsdesk","og_description":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France \u2013 March 26, 2025 \u2013 10:05 PM CET \u2013 Abivax SA (Euronext Paris & Nasdaq: ABVX) (\u201cAbivax\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company focused on developing therapeutics that harness the body\u2019s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announces the filing of its Universal Registration Document (Document d\u2019Enregistrement Universel) with the French Financial Market Authorities, Autorit\u00e9 des March\u00e9s Financiers (AMF), and the filing of its Annual Report (20-F) with the U.S. Securities and Exchange Commission (SEC) on March 24, 2025. The Universal Registration Document includes the 2024 annual financial report, the management report including the report on corporate … Continue reading \"Abivax publishes financial reports with the French and U.S. securities regulatory agencies\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-26T21:08:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies","datePublished":"2025-03-26T21:08:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/"},"wordCount":238,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/","name":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==","datePublished":"2025-03-26T21:08:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3NjM1MSM0MDIxMDI4NDAjMjAyMDExNw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abivax-publishes-financial-reports-with-the-french-and-u-s-securities-regulatory-agencies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Abivax publishes financial reports with the French and U.S. securities regulatory agencies"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=830283"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/830283\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=830283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=830283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=830283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}